Dr. Pablo Shimaoka Chagas is a molecular biologist and cancer researcher at the Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), Brazil, where he leads the research group “From Exposome to Oncology.” He holds a Ph.D. in Genetics from USP and completed postdoctoral training at USP and Augusta University, USA, focusing on tumor biology, immune regulation, and therapeutic resistance. He is currently a Principal Investigator supported by the São Paulo Research Foundation (FAPESP) through a Young Investigator Award. His research explores the interplay between environmental exposures, immunometabolism, inflammation, and cancer, with particular emphasis on kidney disease and renal cell carcinoma. His group investigates how emerging contaminants, including micro- and nanoplastics, influence mitochondrial function, metabolic reprogramming, inflammatory signaling, and tumor progression. His work integrates molecular biology, functional genomics, bioinformatics, and translational models, including 2D and 3D cell cultures, zebrafish, and tumor-on-a-chip systems. Through interdisciplinary collaborations, he aims to advance understanding of the molecular mechanisms linking environmental stressors, kidney dysfunction, and cancer.